ANDA 74634, held by Hospira. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74634 (Dobutamine Hydrochloride), held by Hospira, was first approved by FDA on Sep 27, 1996, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 27, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 1.25GM BASE/100ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Sep 7, 2001 | Supplement 3Manufacturing | Approved | None posted |
| May 21, 1997 | Supplement 2Labeling | Approved | None posted |
| Sep 27, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters